ArticleThe Journal of infection2022

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.

Paula de Michelena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.